相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study
Ping-Ying Chang et al.
PLOS ONE (2019)
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Aakash Desai et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis
Janick Weberpals et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)
Beta-Blockers in Patients With Advanced Liver Disease: Has the Dust Settled?
Carlos Moctezuma-Velazquez et al.
LIVER TRANSPLANTATION (2017)
Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma
Ruzan Udumyan et al.
CANCER RESEARCH (2017)
Beta blockers and cirrhosis, 2016
Mattias Mandorfer et al.
DIGESTIVE AND LIVER DISEASE (2017)
Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection
Zhi-Feng Zhang et al.
BMC GASTROENTEROLOGY (2016)
Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis
Janick Weberpals et al.
CANCER TREATMENT REVIEWS (2016)
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α
Fu-Quan Wu et al.
JOURNAL OF HEPATOLOGY (2016)
Cancer and liver cirrhosis: implications on prognosis and management
Matthias Pinter et al.
ESMO OPEN (2016)
Point: Incident Exposures, Prevalent Exposures, and Causal Inference: Does Limiting Studies to Persons Who Are Followed From First Exposure Onward Damage Epidemiology?
Jan Vandenbroucke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials
Maja Thiele et al.
LIVER INTERNATIONAL (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Sympathetic nervous system regulation of the tumour microenvironment
Steven W. Cole et al.
NATURE REVIEWS CANCER (2015)
Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
Kerstin Schuette et al.
BMC GASTROENTEROLOGY (2014)
Meta-analysis of the effects of beta blocker on survival time in cancer patients
Chel Hun Choi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling
Jun Li et al.
JOURNAL OF HEPATOLOGY (2014)
beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration
Ozlem Darcansoy Iseri et al.
PHARMACEUTICAL BIOLOGY (2014)
Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
Edoardo Botteri et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers
Virginia Hernandez-Gea et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection
Dongtai Chen et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Steven W. Cole et al.
CLINICAL CANCER RESEARCH (2012)
Expression and Functional Coupling of Liver β2-Adrenoceptors in the Human Hepatocellular Carcinoma
Woubet T. Kassahun et al.
PHARMACOLOGY (2012)
Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint
P J Fitzgerald
Clinical Epidemiology (2012)
External review and validation of the Swedish national inpatient register
Jonas F. Ludvigsson et al.
BMC PUBLIC HEALTH (2011)
Biobehavioral Influences on Cancer Progression
Erin S. Costanzo et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2011)
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
Amal Melhem-Bertrandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
beta-Adrenergic Receptors in Cancer: Therapeutic Implications
Mario Perez-Sayans et al.
ONCOLOGY RESEARCH (2010)
The completeness of the Swedish Cancer Register - a sample survey for year 1998
Lotti Barlow et al.
ACTA ONCOLOGICA (2009)
beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis
Marco Senzolo et al.
LIVER INTERNATIONAL (2009)
Further development of flexible parametric models for survival analysis
Paul C. Lambert et al.
STATA JOURNAL (2009)
The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
Bjorn Wettermark et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Prevention and management of Gastroesophageal varices and variceal Hemorrhage in cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2007)
Alpha1- and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma:: density and coupling to adenylate cyclase and phospholipase C
WT Kassahun et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
The selectivity of β-adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors
JG Baker
BRITISH JOURNAL OF PHARMACOLOGY (2005)
分享论文
